Galectin Therapeutics Inc (GALT)
3.64
+0.14
(+4.00%)
USD |
NASDAQ |
Apr 26, 10:49
Galectin Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -0.40M |
| September 30, 2014 | -0.40M |
| June 30, 2014 | -0.40M |
| March 31, 2014 | -0.40M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.056M |
| June 30, 2013 | 0.064M |
| March 31, 2013 | 0.064M |
| December 31, 2012 | 0.064M |
| September 30, 2012 | 0.003M |
| June 30, 2012 | -0.01M |
| March 31, 2012 | -0.015M |
| December 31, 2011 | -0.015M |
| September 30, 2011 | -0.01M |
| June 30, 2011 | -0.005M |
| March 31, 2011 | 0.00 |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 |
| Date | Value |
|---|---|
| March 31, 2009 | |
| December 31, 2008 | 0.009M |
| September 30, 2008 | 0.04M |
| June 30, 2008 | 0.034M |
| March 31, 2008 | -0.021M |
| December 31, 2007 | 4.947M |
| September 30, 2007 | 4.842M |
| June 30, 2007 | 4.762M |
| March 31, 2007 | -0.251M |
| December 31, 2006 | -5.236M |
| September 30, 2006 | -5.155M |
| June 30, 2006 | -5.107M |
| March 31, 2006 | -0.092M |
| December 31, 2005 | -0.111M |
| September 30, 2005 | -0.126M |
| June 30, 2005 | -0.123M |
| March 31, 2005 | -0.0767M |
| December 31, 2004 | -0.069M |
| September 30, 2004 | -0.0815M |
| June 30, 2004 | -0.0683M |
| March 31, 2004 | -0.0874M |
| December 31, 2003 | -0.105M |
| September 30, 2003 | -0.121M |
| June 30, 2003 | -0.1088M |
| March 31, 2003 | -0.1354M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -502.52M |
| Viking Therapeutics Inc | -641.08M |
| 89bio Inc | -123.02M |
| Terns Pharmaceuticals Inc | -37.99M |
| Enanta Pharmaceuticals Inc | -100.26M |